ArticleClinical and translational medicine2025
Developing risk stratification strategies and biomarkers for recurrent hepatocellular carcinoma.
Jia-Hao Law et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it